STARTUP PROFILE

NeuralPulse

COUNTRY
UK
FOUNDED
2025
CATEGORY
Neuromodulation
Creating implantable adaptive neuromodulation that probes brain responses, predicts seizures, and delivers responsive stimulation to prevent them.
Visit website →
Neurofounders Insights
$   Funding   -
Non-dilutive
MODALITY
Intracortical
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Epilepsy
TARGET USER
Patients
REGULATORY STAGE
Investigational
NeuralPulse is positioned in adaptive epilepsy neuromodulation, combining brain-response probing with predictive stimulation in a closed-loop implant architecture. It remains highly early-stage but fits squarely within the broader transition from open-loop to responsive therapies.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
NeuralPulse
No items found.